Cargando…

Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results

BACKGROUND: Although triplet regimen of docetaxel, cisplatin, and 5-FU (DCF) reportedly yields high response rates for metastatic squamous cell carcinoma of the esophagus (SCCE), it has severe toxicity. In our previous phase II trial, grade 3/4 toxicities of neutropenia occurred in 68.8% of the pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ojima, Toshiyasu, Nakamura, Masaki, Nakamori, Mikihito, Katsuda, Masahiro, Hayata, Keiji, Kitadani, Junya, Maruoka, Shimpei, Shimokawa, Toshio, Yamaue, Hiroki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368232/ https://www.ncbi.nlm.nih.gov/pubmed/30783514 http://dx.doi.org/10.18632/oncotarget.26614

Ejemplares similares

Robotic versus laparoscopic gastrectomy with lymph node dissection for gastric cancer: study protocol for a randomized controlled trial
por: Ojima, Toshiyasu, et al.
Publicado: (2018)

Triangulating stapling vs functional end-to-end stapling for cervical esophagogastric anastomosis after esophagectomy for thoracic esophageal cancer: study protocol for a randomized controlled trial
por: Tsuji, Toshiaki, et al.
Publicado: (2019)

Robotic radical lymphadenectomy without touching the pancreas during gastrectomy for gastric cancer
por: Ojima, Toshiyasu, et al.
Publicado: (2019)

Postoperative atrial fibrillation does not impact on overall survival after esophagectomy in patients with thoracic esophageal cancer: results from a randomized, double-blind, placebo-controlled trial
por: Ojima, Toshiyasu, et al.
Publicado: (2020)

Endoscopic treatment of esophageal fistulas after esophagectomy with injection of an alpha-cyanoacrylate monomer: a phase II study
por: Ojima, Toshiyasu, et al.
Publicado: (2018)

Cancer Vaccine Therapy Using Carcinoembryonic Antigen - expressing Dendritic Cells generated from Induced Pluripotent Stem Cells
por: Kitadani, Junya, et al.
Publicado: (2018)

Tumor RNA transfected DCs derived from iPS cells elicit cytotoxicity against cancer cells induced from colorectal cancer patients in vitro
por: Maruoka, Shimpei, et al.
Publicado: (2022)

Comparison of short-term surgical outcomes using da Vinci S, Si and Xi Surgical System for robotic gastric cancer surgery
por: Ojima, Toshiyasu, et al.
Publicado: (2021)

Single-incision laparoscopic antrectomy for type I gastric neuroendocrine tumor: a case report
por: Kitadani, Junya, et al.
Publicado: (2021)

Safety and feasibility of laparoscopic gastrectomy for remnant gastric cancer compared with open gastrectomy: Single-center experience
por: Kitadani, Junya, et al.
Publicado: (2021)

Inhibition of IL-17A in Tumor Microenvironment Augments Cytotoxicity of Tumor-Infiltrating Lymphocytes in Tumor-Bearing Mice
por: Hayata, Keiji, et al.
Publicado: (2013)

Feeding jejunostomy following esophagectomy may increase the occurrence of postoperative small bowel obstruction
por: Nakai, Tomoki, et al.
Publicado: (2022)

Nutritional benefit of remnant gastric preservation in patients with esophageal cancer undergoing radical esophagectomy and ileo-colon interposition
por: Kitadani, Junya, et al.
Publicado: (2022)

Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
por: Kato, Tomoya, et al.
Publicado: (2021)

Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
por: Kato, Tomoya, et al.
Publicado: (2021)

Anticancer effects of chemokine-directed antigen delivery to a cross-presenting dendritic cell subset with immune checkpoint blockade
por: Mizumoto, Yuki, et al.
Publicado: (2020)

Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer
por: Takeuchi, Akihiro, et al.
Publicado: (2019)

Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer
por: Matsumura, Shuichi, et al.
Publicado: (2021)

Esophageal gel-shifting technique facilitating eradicative boost or reirradiation to upper mediastinal targets of recurrent nerve lymph node without damaging esophagus
por: Kishi, Kazushi, et al.
Publicado: (2013)

Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
por: Lee, S-H, et al.
Publicado: (2004)

Laparoscopic distal gastrectomy for synchronous adenocarcinoma, diffuse large B cell lymphoma and gastrointestinal stromal tumor in the stomach: a case report
por: Ojima, Toshiyasu, et al.
Publicado: (2022)

Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
por: Takayama, T, et al.
Publicado: (2007)

MON-603 GPR142 Expression Levels Were Correlated with Plasma Ghrelin Levels and Heights in Morbidly Obese Patients
por: Ueda, Yoko, et al.
Publicado: (2020)

Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer
por: TAS, FARUK, et al.
Publicado: (2013)

Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer
por: Eroglu, Celalettin, et al.
Publicado: (2013)

Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy for unresectable sinonasal undifferentiated carcinoma: Two cases of report
por: Watanabe, Sho, et al.
Publicado: (2019)

Dose of Adenoviral Vectors Expressing Interleukin‐2 Plays an Important Role in Combined Gene Therapy with Cytosine Deaminase/5–Fluorocytosine: Preclinical Consideration
por: Nakamori, Mikihito, et al.
Publicado: (2002)

Antitumor Effects of Interleukin‐2 Gene‐modified Fibroblasts in an Orthotopic Colon Cancer Model
por: Terasawa, Hiroshi, et al.
Publicado: (1999)

Docetaxel, Oxaliplatin and Capecitabine (TEX) triplet regimen as adjuvant chemotherapy in resected gastric adenocarcinoma
por: Thumaty, Divya Bala, et al.
Publicado: (2021)

Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer
por: Yokota, Tomoya, et al.
Publicado: (2016)

C-Reactive protein is an independent surgical indication marker for appendicitis: a retrospective study
por: Yokoyama, Shozo, et al.
Publicado: (2009)

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
por: Jimenez-Fonseca, Paula, et al.
Publicado: (2020)

Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.
por: Hilkens, P. H., et al.
Publicado: (1997)

Docetaxel/cisplatin Therapy in Myasthenia Gravis with Hypertension/diabetes
por: Qi, Guoyan, et al.
Publicado: (2017)

Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease
por: Kawakami, Hisato, et al.
Publicado: (2022)

Mid-esophagus unresectable cancer treated with a low cost stent. First experience
por: Felix, Valter N, et al.
Publicado: (2011)

Long-term outcomes and safety of radical transmediastinal esophagectomy with preoperative docetaxel, cisplatin, and 5-fluorouracil combination chemotherapy for locally advanced squamous cell carcinoma of the thoracic esophagus
por: Yamagata, Yukinori, et al.
Publicado: (2020)

Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
por: Palmerini, E., et al.
Publicado: (2016)

A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma
por: Satake, Hironaga, et al.
Publicado: (2016)

Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis
por: Kim, Jwa Hoon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vuadc7gob2i8rcu2tumem470ri